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A case-control study of risk factors
for asthma in New Zealand children
Kristin Wickens, Julian Crane, Trudi Kemp, Simon Lewis,
Wendyl D’Souza, Gillian Sawyer, Louise Stone, Sarah Tohill,
Jo Kennedy, Tania Slater, Natalie Rains and Neil Pearce
Wellington Asthma Research Group, Wellington School of Medicine, New Zealand
A s in other English-speaking coun-tries, asthma is a major healthproblem in New Zealand with
26% of adults1 and 30% of 13-14 year olds2
reporting wheezing in the past 12 months.
There is evidence also that prevalence is
increasing.3,4 Prevalence studies in New Zea-
land3,5,6 have identified various risk factors
for childhood asthma, including male sex,5,7
parental3,5,6 or sibling asthma,6 or having
eczema during the first year of life.6 How-
ever, there have also been inconsistent find-
ings among these studies, including reports
that paternal asthma5 and parental eczema6
are not significantly related to asthma in the
child, and that the influence of parental
asthma may depend on a child’s gender.8
More recently, a role for vaccination in
promoting allergic sensitisation has been
proposed.9-11 It has been hypothesised that
intracellular infections in early life promote
a predominantly TH1 response, rather than
the TH2 response important in the develop-
ment of atopy.10 In this context, vaccinations
may contribute towards sensitisation because
they reduce clinical infection.
Alternatively, they may directly promote the
development of sensitisation.11 Certainly,
pertussis vaccination has been found to act
as an adjuvant for antigen-specific responses
in laboratory animals.12 There are, however,
few epidemiological studies that have exam-
ined the role of vaccinations in the develop-
ment of atopy or asthma.9,13-17 For these
reasons, we conducted a case-control study
of asthma in childhood and report here the
findings for demographic factors and vacci-
nations.
Methods
The case-control study was based on the
Wellington, New Zealand, arm of the Inter-
national Study of Asthma and Allergies in
Children (ISAAC), which was a study of all
children aged 6-7 and 13-14 from a random
selection of schools. There were 3,318 chil-
dren aged 6-7 years included in the Welling-
ton survey, a response rate of 92%.18 For the
current study, potential cases and potential
controls were each randomly selected from
these 3,318 children.
Recruitment of study subjects
Potential cases and potential controls were
selected from the 3,318 ISAAC Wellington
participants in the younger age group, by
then aged 7-9 (mean age 8.3). The 781 chil-
dren who reported wheezing or whistling in
the chest in the past 12 months and reported
ever having had asthma constituted the sam-
pling frame from which 399 potential cases
were selected at random. In order to limit
the cases to children with current asthma,
screening questions to the parents further
restricted the cases to children with diag-
nosed asthma who had used asthma medi-
cation in the past 12 months.
The 2,113 children who had never had
wheezing or whistling in the chest and who
had never had asthma comprised the sam-
pling frame from which the 398 potential
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controls were selected. Further screening questions ensured that
these children had never had wheezing or whistling in the chest
or a doctor’s diagnosis of asthma.
All schools co-operated in distributing to parents an informa-
tion sheet and a reply form asking for addresses and phone num-
bers. When children had moved to another school within
Wellington since their participation in ISAAC, this school was
invited to co-operate in the study. When children had moved out-
side Wellington they were considered ineligible.
Collection of exposure information
Parents who returned reply forms were contacted and asked the
additional screening questions that determined the final case or
control status of the child. Appointments were made with eligible
respondents to visit them in their homes. When a birth parent
lived separately, permission was asked from the responding par-
ent to contact the absent parent.
Questionnaires recorded information about a variety of demo-
graphic and other possible risk factors for asthma. These included
gender and ethnicity of the child and the occupations of up to two
parents or caregivers in the household. The New Zealand Elley
Irving scale of socio-economic status19 was used to assign social
class codes 1 (highest) to 6 (lowest) according to the occupation
of the parent or caregiver with the higher income. This classifica-
tion groups occupations according to the mean levels of educa-
tion and income. Although households without a parent or
caregiver in employment are excluded from the classification, we
included them as a separate category in the analysis. Information
was also collected on current smoking in the home and smoking
during the first year of life, other atopic diseases in the sampled
child and in birth parents and siblings. Each birth parent was sepa-
rately asked about their own history, with the mother additionally
asked to supply information about previous births, length of ges-
tation, birth weight and infant feeding of the selected child. This
information was also collected from birth parents who lived sepa-
rately and had agreed to participate.
Approximately one year after the main interviews, vaccination
histories were collected blind from the medical notes of the child’s
general practitioner (GP), after permission had been granted by
the parents. When the current GP did not have the vaccination
history, previous GPs were visited. GPs outside Wellington were
written to and asked to complete a vaccination history question-
naire. If notes were not available after contacting all doctors, par-
ents were contacted again and asked to complete a vaccination
history from their child’s Health and Development Record. Vac-
cination questionnaires were coded according to whether records
(either the child’s GP notes or Health and Development Record)
completely covered the period from birth to the survey date, partly
covered this period or there were no records available. Thus, data
that was not based on records was able to be excluded from the
analyses.
Statistical analysis
Data analysis was conducted using SAS. Odds ratios and 95%
confidence intervals (CI) were estimated using the Mantel-
Haenszel method20 for univariate analysis and unconditional
multiple logistic regression21 to adjust for potential confounders.
Results
Of the 399 potential cases selected from the ISAAC survey, 97
were ineligible: eight had never had a doctor’s diagnosis of asthma;
60 had not used medication in the past 12 months; 24 had moved
away from Wellington; four had moved but their whereabouts was
unknown and the reason for ineligibility was not recorded for
one potential case. Of the 398 potential controls, 50 were ineligi-
ble: 14 had reported wheezing or whistling in the chest at some-
time in the past; five had had a doctor’s diagnosis of asthma; 29
had moved away from Wellington; and two had moved but their
whereabouts was unknown. Among the eligible population, 233
(77%) cases and 241 (69%) controls participated in the study (see
Table 1).
For the vaccination arm of the study, 11 of the 233 participat-
ing cases had moved and could not be traced and two cases
declined to provide the name of the child’s current doctor. Simi-
larly, five of the 241 controls had moved and could not be traced,
one control refused and four controls declined to provide the name
of the child’s current doctor. The children of parents who did not
supply doctor’s names were excluded from the vaccination analy-
ses. Among those included in the main analysis, there were 194
cases and 204 controls with records available since birth, 17 cases
and 16 controls where records were available for only some of the
period, and 9 cases and 11 controls where no records were
located.
Table 2 shows that male sex was associated with twice the risk
of asthma and having parents in social classes 5 or 6, or unem-
ployed, was associated with a small increased risk for asthma,
with some evidence of a dose response. Stratification of the data
by ethnicity showed that the effect of social class on asthma was
independent of ethnicity.
Table 3 shows that maternal asthma, eczema and hayfever,
paternal asthma, eczema and hayfever and sibling asthma were
factors significantly associated with asthma. Either parent hav-
ing asthma was also strongly associated with asthma in the child
(OR=3.79, 95% CI 2.57-5.61), and this was stronger for boys
(OR=4.11, 95% CI 2.39-7.08) than girls (OR=3.11, 95% CI 1.74-
5.56). When both parents had asthma, the odds ratio increased to
9.95 (95% CI 2.84-34.88) compared with neither parent having
Table 1: Response rates of cases and controls.
Cases Controls
ISAAC sample 399 398
Ineligibles 97 50
Eligible sample 302 (100%) 348(100%)
Refused 44 (15%) 69 (20%)
No response 25 (8%) 38 (11%)
Respondents 233 (77%) 241 (69%)
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asthma, and this was similar for girls (OR=10.49, 95% CI 1.76-
62.53) and boys (OR=9.11, 95% CI 1.53-54.27) (not shown in
tables).
We found little or no association between length of gestation,
birth weight, breastfeeding, number of months breastfed, or the
introduction of cow’s milk in the first year of life (defined to
exclude cow’s milk-based formula) for either breastfed or for-
mula-fed infants and asthma (see Table 4). Among asthmatic chil-
dren, breastfed children were less likely to develop their first
symptoms under one year of age (OR=0.37, 95% CI 0.15-0.93).
Maternal smoking during pregnancy did not increase the risk
of asthma. There was also no relationship between maternal, pa-
ternal or any smoking in the house, the number of smokers, and
the number of cigarettes smoked during the first year of the child’s
life and asthma. For current smoking, although these same vari-
ables were associated with odds ratios greater than one, these were
mostly weak and not significant. The exception was any smoking
in the house currently which showed a marginally significant
increased risk of asthma (OR=1.44, 95% CI 0.99-2.09).
Vaccinations
Most vaccinations showed non-significantly elevated odds
ratios for asthma when compared with children who had not had
Table 3: Odds ratios and 95% confidence intervals for
the association between asthma in New Zealand
children and atopic disease in siblings and parents.
Cases Controls OR 95% CI
(n=233) (n=241)
Sibling asthmaa
Yes 123 81 2.78*** 1.88-4.11
No 76 139 1.00b
Sibling eczemaa
Yes 109 99 1.44 0.98-2.12
No 91 119 1.00b
Sibling hayfevera
Yes 60 54 1.30 0.85-2.02
No 134 158 1.00b
Maternal asthma
Yes 75 31 3.24*** 2.05-5.10
No 154 206 1.00b
Maternal eczema
Yes 83 54 1.96*** 1.31-2.93
No 143 182 1.00b
Maternal hayfever
Yes 103 77 1.74** 1.20-2.54
No 122 159 1.00b
Paternal asthmaa
Yes 56 23 3.02*** 1.81-5.06
No 153 190 1.00b
Paternal eczemaa
Yes 51 33 1.71* 1.05-2.79
No 156 173 1.00b
Paternal hayfevera
Yes 95 64 1.92*** 1.29-2.86
No 113 146 1.00b
Notes:
(a) Numbers do not add up to totals because children without siblings or
paternal data available were not included in defining these variables.
(b) Reference category
* p<0.05, ** p<0.01, *** p≤ 0.001
Table 4: Odds ratios and 95% confidence intervals for
the association between asthma in New Zealand
children and gestation, birth weight and infant diet.
Cases Controls OR 95% CI
(n=233) (n=241)
Whether born early
Yes 62 54 1.27 0.83-1.93
No 166 183 1.00a
Number of weeks early
0 166 183 1.00a
1 15 11 1.50 0.67-3.35
2 24 24 1.10 0.60-2.02
3 7 7 1.10 0.38-3.21
≥4 16 12 1.47 0.68-3.19
Birth weight (kg)
≤2.5 15 16 0.92 0.44-1.92
>2.5 and <4 179 176 1.00a
≥4 29 38 0.75 0.44-1.27
Whether breastfed
Yes 208 219 0.91 0.48-1.72
No 21 20 1.00a
Months breastfed
Not breastfed 21 20 1.00a
>0-4 51 59 0.82 0.40-1.69
>4-8 45 51 0.84 0.40-1.75
>8-12 65 59 1.05 0.52-2.13
>12 47 50 0.90 0.43-1.86
Introduction of cow’s milk
<1 year 144 151 1.00 0.66-1.51
≥1 year 63 66 1.00a
Note:
(a) Reference category.
Table 2: Odds ratios and 95% confidence intervals for
the association between asthma in New Zealand
children and demographic characteristics.
Cases Controls OR 95% CI
(n=233) (n=241)
Sex
Female 91 134 1.00a
Male 142 107 1.95* 1.36-2.81
Ethnicity
European/Other 177 187 1.00a
Maori 36 31 1.23 0.73-2.07
Pacific Island 20 23 0.92 0.49-1.73
Social Class
1 & 2 106 118 1.00a
3 44 52 0.94 0.58-1.52
4 30 28 1.19 0.67-2.13
5 & 6, unemployed 53 43 1.36 0.86-2.13
Notes:
(a) Reference category.
* p<0.001
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that vaccination (see Table 5). The exception was MMR (mea-
sles, mumps and rubella) where the positive association was sta-
tistically signif icant. Hepatitis B vaccination showed a
non-significant negative association with asthma. The exclusion
from the analysis of data not based on records increased the asso-
ciation between polio and asthma, but did not change the asso-
ciation between hepatitis B or MMR and asthma.
Although children in social classes 1 and 2 were more likely to
have received any vaccination (OR=1.56, 95% CI 0.37-6.61) than
children in social classes 5 and 6 or children of unemployed par-
ents, this was not significant. Children in social classes 1 and 2
were also more likely to have received DPT (diphtheria, pertus-
sis, tetanus) (OR=2.59, 95% CI 1.16-5.81), polio (OR=2.08, 95%
CI 0.76-5.69), MMR (OR=1.77, 95% CI 0.95-3.32), any measles
containing vaccine (OR=1.64, 95% CI 0.84-3.22) or both mea-
sles containing vaccines (OR=1.85, 95% CI 0.91-3.74). They were
also slightly less likely to have had hepatitis B vaccination
(OR=0.85, 95% CI 0.51-1.42).
MMR was the only vaccine that first-born children were signifi-
cantly more likely to have had than third or later-born children
(OR=2.30, 95% CI 1.36-3.89). They were also significantly more
likely to have had both measles containing vaccines (OR=2.44,
95% CI 1.36-4.38) but only slightly more likely to have had the
MMR vaccine and not the measles vaccine (OR=1.36, 95% CI 0.53-
3.51).
Multivariate analysis
The multivariate analysis (see Table 6) assessed the independ-
ent effects of all variables that were strongly or significantly
related to asthma in the univariate analysis, including exposures
Table 5: Odds ratios and 95% confidence intervals for
the association between asthma in New Zealand
children and vaccinations.
Vaccination Cases Controls OR 95% CI
(n=220) (n=231)
Any DPT
Yes 205 208 1.51 0.77-2.97
No 15 23 1.00a
Any DT or DPT
Yes 207 212 1.43 0.69-2.96
No 13 19 1.00a
Any Hepatitis B
Yes 125 149 0.72 0.50-1.06
No 95 82 1.00a
Any polio
Yes 212 214 2.11 0.90-4.90
No 8 17 1.00a
Measles or MMR
Yes 194 192 1.52 0.89-2.58
No 26 39 1.00a
MMR
Yes 68 50 1.62* 1.06-2.47
No 152 181 1.00a
BCG
Yes 7 6 1.23 0.41-3.72
No 213 225 1.00a
Note:
(a) Reference category.
* p<0.05
Table 6: Adjusteda odds ratios and 95% confidence
intervals for the association between asthma in New
Zealand children and demographic, family history,
vaccination and environmental smoke exposure.
Cases Controls OR 95% CI
(n=233) (n=241)
Gender
Female 91 134 1.00b
Male 142 107 1.81** 1.17-2.81
Social class
1&2 106 118 1.00b
3 44 52 1.03 0.58-1.83
4 30 28 1.69 0.82-3.48
5&6, unemployed 53 43 2.32* 1.22-4.44
Maternal asthma
Yes 75 31 3.36*** 1.88-5.99
No 154 206 1.00b
Paternal asthmac
Yes 56 23 2.67** 1.42-5.02
No 153 190 1.00b
Maternal eczema
Yes 83 54 1.80* 1.10-2.92
No 143 182 1.00b
Paternal eczemac
Yes 51 33 1.32 0.73-2.37
No 156 173 1.00b
Maternal hayfever
Yes 103 77 1.37 0.85-2.19
No 122 159 1.00b
Paternal hayfeverc
Yes 95 64 1.96** 1.21-3.18
No 113 146 1.00b
Current smoking
Yes 95 78 1.65 0.91-3.01
No 138 163 1.00b
Vaccinations (n=220) (n=231)
Any hepatitis B
Yes 125 149 0.66 0.42-1.04
No 95 82 1.00b
Any polio
Yes 212 214 2.48 0.83-7.41
No 8 17 1.00b
MMR
Yes 68 50 1.43 0.85-2.41
No 152 181 1.00b
Notes:
(a) Adjusted for all variables shown in table plus family size, measles and
whooping cough infection, child care use in the first year of life, sheepskin
use in the first year of life, current use of a water bed or plastic sheet on
mattress, age of mattress and any current smoking in house.
(b) Reference category.
(c) Numbers do not add up to totals because children without paternal data
available were not included in defining this variable.
* p<0.05, ** p<0.01, *** p=0.0001.
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whose associations with asthma are reported elsewhere.22,23 These
included gender, social class, maternal and paternal asthma, fam-
ily size, child care use in the first year of life, whooping cough
and measles infection, hepatitis B, polio and MMR vaccination,
sheepskin use in the first year of life, current use of a waterbed or
plastic sheet on the mattress, age of mattress and any current smok-
ing in the house. Sibling asthma, hayfever or eczema were not
included in the model because information on maternal and
paternal asthma, eczema and hayfever was available to allow for
direct control for family history of asthma.
Having maternal or paternal asthma, maternal eczema or pater-
nal hayfever, or being male remained significant risk factors in
the multivariate analysis. Children from social classes 5 and 6 or
with unemployed parents were also significantly more likely to
have asthma than children in social classes 1 and 2. The effect of
current smoking in the home increased, but its significance
reduced. The associations of hepatitis B and polio with asthma
were virtually unchanged, compared with the univariate analysis.
The significant univariate association between MMR vaccination
and asthma was found to be due to confounding by the variables
for measles infection and polio vaccination. To assess the influ-
ence of social class on asthma independently of birth weight and
gestational age, these variables were added to the model but did
not alter the social class effect. Replacing the variable for family
size with the variable for birth order did not change the outcome
of the model.
A further model that combined the variables for skin prick test
positivity to Dermatophagoides pteronyssinus, Dermatophagoides
farinae and cat with the gender variable showed a reduction in
the odds ratio for male sex from 1.95 to 1.59 (95% CI 1.06-2.38),
suggesting that some of the gender difference may occur through
mechanisms involving atopy to these allergens.
Discussion
Demographic factors
Many studies have found that boys are at almost twice the risk
of developing asthma than girls.6,7 We found a similar effect in
the univariate analysis; some of this effect was explained by atopy
to dust mites and cat in the multivariate analysis. Sears et al.24
also found that gender differences for asthma reduced after ad-
justment for skin-test responsiveness to house dust mite and/or
cat. Reasons for the residual excess prevalence among boys are
unknown.
Our finding of increased asthma prevalence in lower social
classes is consistent with the findings of Strachan et al.,25 who
found a trend towards more current wheeze in less privileged
classes. The reasons why less advantaged children should have
more asthma are unclear. Lower social class status may be an
indicator of other factors associated with asthma such as low ges-
tational age,26 low birth weight26 and smoking.27,28 However,
adjusting for these variables did not alter the effect of social class
on asthma. Another possible explanation for our findings is that
the relatively small numbers of our study population in the lower
social classes reflect a lower response rate in this group and our
findings could be due to selection bias if the response rate was
also related to disease status. In addition, it should be noted that
social class may be associated with asthma exacerbations (and
hence the prolongation of symptomatic periods) rather than asthma
incidence.29
Family history
A family history of asthma is also a frequently reported risk
factor for asthma, which our study confirmed.5,7,8,26,30 Fergusson,
in a New Zealand cohort study, found that the association
between parental asthma and asthma in four-year-old children was
true for boys but not girls, and concluded that the expression of
asthma in genetically susceptible female children is delayed until
middle childhood compared with its earlier expression in geneti-
cally susceptible boys.8 The older age (7-9 years) of the children
in our study may explain why we did not find such clear gender
differences in the association between parental asthma and child-
hood asthma. After adjusting for possible confounders we found
a greater influence of maternal versus paternal asthma on asthma
in the child. This is consistent with the New Zealand study by
Sears et al.5
Breastfeeding
We found no effect of breastfeeding on asthma prevalence at
age 7-9. However, breastfeeding seems to delay the onset of asthma
symptoms, possibly because it protects against wheezing associ-
ated with infectious respiratory illness in infancy.
Parental smoking
Although we found no effect of early life exposures to tobacco
smoke on the prevalence of asthma, we have shown a marked
increase in the risk of asthma (OR=1.65) associated with current
smoking in the home. A recent review of parental smoking
reported that although environmental tobacco smoke was associ-
ated with small increased risks of asthma these were important
because of the large number of children exposed to smoking in
the home.31 This is supported in our study where 41% of asthmat-
ics lived with a smoker.
Vaccinations
Overall, we found little evidence of an association between
vaccination and asthma; although the odds ratios for some vacci-
nations were non-significantly elevated, this small increased risk
could be due to the method of case selection. For example, if the
cases were more likely to have had access to medical care they
would therefore be more likely to have been vaccinated. Further-
more, for most vaccinations, only small numbers of children were
unexposed, and it is possible that some of these children did
receive vaccinations that were not recorded. Thus, our findings
should be considered with caution.
The significant univariate association of MMR vaccination with
asthma was found to be due to confounding by measles infection
and polio vaccination. Nevertheless, after adjustment, the
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association for MMR with asthma remained positive, which is
consistent with a recent study of Steiner schools where children
not receiving the MMR vaccination were significantly less likely
to be atopic.32 Since MMR was not introduced into New Zealand
until 1990 (when the children in our study were aged about 4-6
years) the uptake of this vaccination was low but higher among
children of low birth order and high social class. However,
adjusting for these possible confounders did not substantially
reduce the effect of MMR on asthma.
Hepatitis B was also introduced as a universal vaccination in
New Zealand in 1990. Our finding of a weak negative associa-
tion for hepatitis B vaccination is of interest in light of the protec-
tive effect of Hepatitis A infection found by Matricardi et al.33 To
confirm our findings, a study of approximately twice the size
would be required.
The later universal introduction of MMR and hepatitis B vac-
cination meant that there were more children in the non-exposed
comparison group, increasing our confidence in the results. Nev-
ertheless, our findings for vaccinations are inconclusive, and fu-
ture studies should involve a sample of all asthmatics (rather than
diagnosed asthmatics) in populations that include a significant
proportion of non-vaccinated children.
Finally, caution is needed in the interpretation of the study
results; since we examined many factors some will be significant
by chance alone.
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